Murli Krishna Pharma Pvt. Ltd.
-
Upload
murli-krishna-pharma -
Category
Health & Medicine
-
view
3.955 -
download
5
description
Transcript of Murli Krishna Pharma Pvt. Ltd.
Murli Krishna Pharma Pvt. Ltd.Innovative Solutions for Oral Dosage
Forms…..
Factory :
D-98, Ranjangaon, M.I.D.C., Ranjangaon, Taluka-Shirur, District – Pune, 412209 – Maharashtra.TEL.:00-91-2138 660771,660772. Fax: 00-91-2138232530.
Cop. Office:
No. 8, Pearl Bldg., Powai Vihar Complex, A.S.Marg, Powai, Mumbai – 400 076. India.Tel. : 00-91-22-25708138/3598/Fax : 00-91-22-25702054.Email: [email protected] Web Site: www.mkppl.com
……….we turn ideas into technology
Company Profile
• MKPPL is a Research based company manufacturing high value drug products in the form of Enteric Coated Pellets.
• European GMP certified plant for Omeprazole pellets
• 100% Export Oriented Unit (EOU)
• Single stop for Coating Solutions
• Commercial Production started in October 2005
• Compliance with regulatory standards – Both Indian and International
Vision
• Turning Technology dreams into reality.
Mission• Become a Global Pharmaceutical export company
• Continuing the development of Aqueous based Coating Techniques .
• Extending our expertise in designing Solid Dosage forms for Stents moving from the current Micro Encapsulation to Nano Encapsulation Using Aqueous Dispersion Techniques.
• Focusing on New and Novel Drug Deliveries with an eye on Patents
Our Strengths
• Right products
• Right people
• Right infrastructure
• Right environment
• Deliver quality product on time at competitive price
• Right quality procedures in practice
Right Products
*Patent non infringing *Patent non infringing
Product Strength Pellet Size
Category
Omeprazole Pellets 8.5%,10 % 14#1816#20
Anti-ulcerant
Lansoprazole Pellets 8.5% 14#1824#30
Anti-ulcerant
Itraconazole Pellets 22% 14#18 Anti-ulcerant
Esomeprazole Pellets 8.5% & 22.5%,22%
14#1816#20
Anti-ulcerant
Pantoprazole Pellets 15% ,22% 14#18 Anti-ulcerant
Tacrolimus Pellets 0.5%, 1% & 5% --- Immune-Suppressant
Clarithromycin Pellets 40% 20#30 Macrolide
Orlistat Pellets 50% -- Anti-obesity
Mesalazine Pellets 70% ---- Anti-ulcerant
Right Products
New Molecules in pipeline•Rapamycin (Sirolimus) Pellets 0.5%, 1%, 5%
•Mycophenolate Mofitil Pellets 50%
•Paclitaxel Pellets 25%, 50%
•Azithromycin Pellets 40%
We have a dedicated manufacturing facility for Immune-Suppressant Pellets
Total Plant Capacity at present : 12 MT Per Month
Advantage in using Enteric coated pellets Manufactured by MKPPL
• Ready to fill any size of capsules.
• No processing prior to capsule and dry syrup filling resulting.
in substantial cost and time saving.
• Easy to make dry syrup for children.
• No organic solvents used during coating or at any other stage
of manufacturing.• Better in-vitro and in-vivo absorption profile (matching with
innovators profile) for long term Pharmacological action
Right people Experienced work force and management team
Department M.Pharm B.Pharm M.Sc B.Sc/B.E B.Com M.Com/M.A
D.Pharm/D.E Other Total
Production 0 3 1 3 0 0 2 6 15
Quality Assurance
35 1 2 0 0 0 0 11
Quality Control 0 3 6 1 0 0 2 0 12
Warehouse 0 0 0 1 1 0 0 3 5
Engineering 0 0 0 0 0 0 1 7 8
Human Resources
0 0 0 0 0 2 0 0 2
Administration 0 0 0 0 0 1 1 2 5
Product Development Lab.
4 1 1 0 0 0 0 1 7
I.T. 0 0 0 1 0 0 0 0 1
Total 66
ORGANOGRAM
Director AdministrationMrs. Sitamahalakshmi
Challa
Director AdministrationMrs. Sitamahalakshmi
Challa
Technical DirectorDr. Vijay K. Shastri
Technical DirectorDr. Vijay K. Shastri
GM Manufacturing
Operations Mr. A. V. Kulkarni
GM Manufacturing
Operations Mr. A. V. Kulkarni
LogisticsLogistics
CMDMrs. Satya R. Vadlamani
CMDMrs. Satya R. Vadlamani
PurchasePurchase
FDA Liaison
Mr. K. V. Narale
FDA Liaison
Mr. K. V. Narale
Chief Finance OfficerMr. R. V. Ranjan
Chief Finance OfficerMr. R. V. Ranjan
Director Business Development & Technical Services
Dr. Pramod P. Karkhanis
Director Business Development & Technical Services
Dr. Pramod P. Karkhanis
Material Management & Procurement
Material Management & Procurement
Material Inventory Control
&
Product Inventory
Control
Material Inventory Control
&
Product Inventory
Control
DGM QC
Ms. Sushila Kumari
DGM QC
Ms. Sushila Kumari
Human Resources
Human Resources
Global Business Development, Global
Regulatory Compliance Ms.Tahera Dashti
Global Business Development, Global
Regulatory Compliance Ms.Tahera Dashti
Head Process Development Laboratory
Mr. T. Phanikumar
Head Process Development Laboratory
Mr. T. Phanikumar
Research &
Development
Research &
Development
Head Accounts Department
Ms. S. S. More
Head Accounts Department
Ms. S. S. More
GM Quality Assurance &
Regulatory AffairsMr. R. B. Patil
GM Quality Assurance &
Regulatory AffairsMr. R. B. Patil
DGM Quality Assurance & Regulatory compliance
Mr.S.B.Bhalekar
Mr. S. B. Bhalekar
DGM Quality Assurance & Regulatory compliance
Mr.S.B.Bhalekar
Mr. S. B. Bhalekar
Manager Engineering & Maintenance
Mr. D. M. Deshmukh
Manager Engineering & Maintenance
Mr. D. M. Deshmukh
Senior DGM ProductionSenior DGM Production
Material Handling, Store , Dispatch, Distribution.
Mr. T.K.Halande
Material Handling, Store , Dispatch, Distribution.
Mr. T.K.Halande
Asst.Mgr. QA&RA
Ms.Kavita Godase
Asst.Mgr. QA&RA
Ms.Kavita Godase
Management Team
• Mrs. Satya Vadlamani
Chairperson and Managing Director
• Dr. Vijay K Shastri
Director-Technical
• Dr.Pramod P. Karkhanis
Director-Business Development and Technical Services.
• Mrs. C. Sitamahalaxmi
Director – Administration
• Mr. Ranjan
CFO- Finance
Our Partners in Venture
• Rhenochem AG- Switzerland
Equity holders as well as marketing partners in Europe and
South America
• Elcon Hongkong Ltd.---Hongkong
Equity holders as well as marketing represntatives in China
Our clientele
European USA• Medichrom — Greece
• Farmoz — Portugal
• Slavia Pharm — Romania
• Welding Gmbh — Germany
• Rhenochem AG – Switzerland
• Karieb Kemi – UK
• Mylan Inc.
•Cutis Pharma Inc.
•Cogentus
Pharmaceuticals Inc.
•Geo Pharma Inc.
•Neuromoleculuar
Synthesis
Thank You!